StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Earnings Growth 'Underappreciated' - Cantor Fitzgerald
July 28, 2022 1:32 PM
Pfizer (NYSE: PFE) topped estimates when it reported earnings for the second quarter premarket Thursday. The drugmaker reported a profit ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Earnings
Hot List
Next Articles
Pfizer leaves COVID product forecast unchanged, shares fall
July 28, 2022 6:50 AM
Pfizer (PFE) Tops Q2 EPS by 33c, Reaffirms FY22 Comirnaty and Paxlovid Sales Guidance
July 28, 2022 6:46 AM
PFIZER REPORTS SECOND-QUARTER 2022 RESULTS
July 28, 2022 6:45 AM